Steen H. Ingwersen

Body Composition Is the Main Determinant for the Difference in Type 2 Diabetes Pathophysiology Between Japanese and Caucasians

Jonas Bech Møller, Maria Pedersen, Haruhiko Tanaka et al. · Diabetes Care · 2013 · 145 citations · Full text

Medicine, Endocrinology, Physiology +15

Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials

Rune Viig Overgaard, Andrea Navarria, Steen H. Ingwersen et al. · Clinical Pharmacokinetics · 2021 · 114 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Ethnic Differences in Insulin Sensitivity, β-Cell Function, and Hepatic Extraction Between Japanese and Caucasians: A Minimal Model Analysis

Jonas Bech Møller, Chiara Dalla Man, Rune Viig Overgaard et al. · The Journal of Clinical Endocrinology & Metabolism · 2014 · 103 citations · Full text

Medicine, Endocrinology, Internal Medicine +16

Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes

Rune Viig Overgaard, CHRISTIN L. HERTZ, Steen H. Ingwersen et al. · Cell Reports Medicine · 2021 · 100 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Population Pharmacokinetics of Liraglutide, a Once‐Daily Human Glucagon‐Like Peptide‐1 Analog, in Healthy Volunteers and Subjects With Type 2 Diabetes, and Comparison to Twice‐Daily Exenatide

Estelle Watson, Daniël M. Jonker, Lisbeth V. Jacobsen et al. · The Journal of Clinical Pharmacology · 2010 · 53 citations

Pharmacy, Pharmacokinetics, Pharmacology +13